Personal information

No personal information available

Activities

Collapse all

Works (11)

Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating Lymphocytes

Cancer Immunology Research
2023-05-03 | Journal article
DOI: 10.1158/2326-6066.CIR-22-0761
Contributors: Zachary L.Z. Hay; Jennifer R. Knapp; Roman E. Magallon; Brian P. O'Connor; Jill E. Slansky
Source: check_circle
Crossref

Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8+ T Cell Immunity

Cancers
2022-09-09 | Journal article
DOI: 10.3390/cancers14184397
Contributors: Faye A. Camp; Tonya M. Brunetti; Michelle M. Williams; Jessica L. Christenson; Varsha Sreekanth; James C. Costello; Zachary L. Z. Hay; Ross M. Kedl; Jennifer K. Richer; Jill E. Slansky
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity

International Journal of Molecular Sciences
2022-02-06 | Journal article
DOI: 10.3390/ijms23031833
Contributors: Zachary L. Z. Hay; Jill E. Slansky
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Implications of Antigen Selection on T Cell-Based Immunotherapy

Pharmaceuticals
2021-09-29 | Journal article
DOI: 10.3390/ph14100993
Contributors: Faye Camp; Jill Slansky
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer

Proceedings of the National Academy of Sciences
2021-06-08 | Journal article
DOI: 10.1073/pnas.2100588118
Contributors: Pengcheng Wei; Kimberly R. Jordan; Jonathan D. Buhrman; Jun Lei; Hexiang Deng; Philippa Marrack; Shaodong Dai; John W. Kappler; Jill E. Slansky; Lei Yin
Source: check_circle
Crossref

MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

npj Breast Cancer
2021-05-27 | Journal article
DOI: 10.1038/s41523-021-00273-1
Contributors: Michelle M. Williams; Jessica L. Christenson; Kathleen I. O’Neill; Sabrina A. Hafeez; Claire L. Ihle; Nicole S. Spoelstra; Jill E. Slansky; Jennifer K. Richer
Source: check_circle
Crossref

T‐cell receptor affinity in the age of cancer immunotherapy

Molecular Carcinogenesis
2020-07 | Journal article
DOI: 10.1002/mc.23212
Contributors: Michele M. Hoffmann; Jill E. Slansky
Source: check_circle
Crossref

The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval

2020-04-15 | Other
DOI: 10.1101/2020.04.14.041145
Contributors: Kimberly R. Jordan; Matthew J. Sikora; Jill E. Slansky; Angela Minic; Jennifer K Richer; Marisa R. Moroney; James C. Costello; Aaron Clauset; Kian Behbakht; T. Rajendra Kumar et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8+ T-cell responses by upregulating MHC-I expression

Oncogene
2019-11-14 | Journal article
DOI: 10.1038/s41388-019-0911-6
Contributors: Joseph A. Westrich; Daniel W. Vermeer; Alexa Silva; Stephanie Bonney; Jennifer N. Berger; Louis Cicchini; Robert O. Greer; John I. Song; David Raben; Jill E. Slansky et al.
Source: check_circle
Crossref

Alternative Splicing in Tumors — A Path to Immunogenicity?

New England Journal of Medicine
2019-02-28 | Journal article
DOI: 10.1056/NEJMcibr1814237
Contributors: Jill E. Slansky; Elizabeth G. Phimister; Paul T. Spellman
Source: check_circle
Crossref

A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Molecular Cancer Research
2019-01-01 | Journal article
DOI: 10.1158/1541-7786.MCR-18-0362
Contributors: Lisa I. Greene; Tullia C. Bruno; Jessica L. Christenson; Angelo D'Alessandro; Rachel Culp-Hill; Kathleen Torkko; Virginia F. Borges; Jill E. Slansky; Jennifer K. Richer
Source: check_circle
Crossref
How many people are using ORCID?